Physician profile
Eric A Levine
NPI 1689626020
$12,055.72
in general payments reported to CMS, 2019-2025
20 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.35 · 2020: $16.11 · 2022: $215 · 2023: $114 · 2024: $11K · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $11K · Food and Beverage: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $11,200.00 |
| Food and Beverage | $564.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $11,235.66 | 2023-2024 | |
| Paratek Pharmaceuticals, INC. | $98.96 | 2024 | Nuzyra |
| Triad Life Sciences INC. | $86.92 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $66.00 | 2024-2025 | |
| Averitas Pharma INC. | $64.86 | 2024-2025 | Qutenza |
| Organogenesis INC. | $61.54 | 2022 | |
| Reprise Biomedical, INC. | $56.80 | 2024 | Miro3d |
| Kerecis Limited | $49.46 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Stryker Corporation | $43.17 | 2019-2025 | Fuseforce |
| Pfizer INC. | $42.47 | 2024 | |
| Mimedx Group, INC. | $41.13 | 2024-2025 | |
| Zimvie INC. | $38.06 | 2022 | |
| Abbvie INC. | $29.05 | 2023 | |
| Nevro Corp. | $28.23 | 2022 | |
| Solventum Corporation | $21.95 | 2025 | Promogran Prisma, 3m Coban, V.A.C. Dermatac |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ebi, LLC | $21.87 | 2025 | Biomet Ebi Bone Healing System, Biomet Orthopak Non-Invasive Bone Growth Stimulator System |
| Axogen | $20.65 | 2019 | |
| Djo, LLC | $18.36 | 2025 | Cmf |
| Alfasigma USA, INC. | $16.11 | 2020 | |
| Integra Lifesciences Corporation | $14.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.